![Results of multigene panel testing in familial cancer cases without genetic cause demonstrated by single gene testing | Scientific Reports Results of multigene panel testing in familial cancer cases without genetic cause demonstrated by single gene testing | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-54517-z/MediaObjects/41598_2019_54517_Fig1_HTML.png)
Results of multigene panel testing in familial cancer cases without genetic cause demonstrated by single gene testing | Scientific Reports
![About the Multi-Gene Panel Test for Hereditary Breast and Ovarian Cancer | Memorial Sloan Kettering Cancer Center About the Multi-Gene Panel Test for Hereditary Breast and Ovarian Cancer | Memorial Sloan Kettering Cancer Center](https://www.mskcc.org/sites/default/files/patient_ed/_shared/genetics_breast_ovarian_071521.png)
About the Multi-Gene Panel Test for Hereditary Breast and Ovarian Cancer | Memorial Sloan Kettering Cancer Center
![Breast cancer: targeting the genome for better surveillance and treatment – HudsonAlpha Institute for Biotechnology Breast cancer: targeting the genome for better surveillance and treatment – HudsonAlpha Institute for Biotechnology](https://s3.amazonaws.com/hudsonalpha/wp-content/uploads/2021/10/13121518/EDNA_BreastCancerFactors.png)
Breast cancer: targeting the genome for better surveillance and treatment – HudsonAlpha Institute for Biotechnology
![Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women | JCO Precision Oncology Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women | JCO Precision Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/po/2017/po.2017.1/po.16.00066/20170623/images/large/po.16.00066t3.jpeg)
Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women | JCO Precision Oncology
![A multi-gene panel beyond BRCA1/BRCA2 to identify new breast cancer-predisposing mutations by a picodroplet PCR followed by a next-generation sequencing strategy: a pilot study - ScienceDirect A multi-gene panel beyond BRCA1/BRCA2 to identify new breast cancer-predisposing mutations by a picodroplet PCR followed by a next-generation sequencing strategy: a pilot study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0003267018311036-fx1.jpg)
A multi-gene panel beyond BRCA1/BRCA2 to identify new breast cancer-predisposing mutations by a picodroplet PCR followed by a next-generation sequencing strategy: a pilot study - ScienceDirect
![Cancers | Free Full-Text | Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior BRCA1/2 Probability Cancers | Free Full-Text | Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior BRCA1/2 Probability](https://pub.mdpi-res.com/cancers/cancers-13-04154/article_deploy/html/images/cancers-13-04154-g001-550.jpg?1629294747)
Cancers | Free Full-Text | Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior BRCA1/2 Probability
![A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients | Genetics in Medicine A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients | Genetics in Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41436-019-0633-8/MediaObjects/41436_2019_633_Fig2_HTML.png)
A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients | Genetics in Medicine
Gene panel screening for insight towards breast cancer susceptibility in different ethnicities | PLOS ONE
![Update: variable implementation of the 2018 UKCGG/UKGTN guidelines for breast cancer gene panel tests offered by UK genetics services | Journal of Medical Genetics Update: variable implementation of the 2018 UKCGG/UKGTN guidelines for breast cancer gene panel tests offered by UK genetics services | Journal of Medical Genetics](https://jmg.bmj.com/content/jmedgenet/58/8/579/F1.large.jpg)